Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Top BPC-157 Studies: Research Category Comparison

Gastric Protection (1991–2010) Nitric oxide modulation, mucus stabilisation, microvascular blood flow NSAID-induced ulcers, ethanol damage, cysteamine lesions High. Consistent dose-response, multiple research groups, quantifiable histological endpoints Human t

This comparison does not assign a generated winner or score.

  • Gastric Protection (1991–2010)
  • Nitric oxide modulation, mucus stabilisation, microvascular blood flow
  • NSAID-induced ulcers, ethanol damage, cysteamine lesions
  • High. Consistent dose-response, multiple research groups, quantifiable histological endpoints
  • Human trials limited to case reports; optimal dosing and administration route for clinical use undefined
  • Most robust evidence base; mechanism well-characterised across multiple injury models with reproducible results
  • Musculoskeletal Repair (2009–2018)
  • VEGF upregulation, angiogenesis at injury sites, collagen organisation
  • Achilles tendon transection, MCL tears, crush injuries to skeletal muscle
  • Moderate. Surgical models with controlled injuries; biomechanical testing standardised
  • Acute injury models only; chronic tendinopathy and overuse conditions underrepresented; human dosing extrapolation unclear
  • Convincing acute injury data; effect size clinically meaningful but overstated in non-peer-reviewed sources
  • Neuroprotection (2016–2023)
  • Dopamine pathway modulation, oxidative stress reduction, BBB integrity
  • Traumatic brain injury, amphetamine/haloperidol-induced disruption
  • Moderate. Emerging field with fewer replication studies; mechanisms incompletely characterised
  • Blood-brain barrier crossing pathway unclear; delayed-treatment protocols ineffective; no human neurological case data
  • Promising preclinical signals; insufficient data to support cognitive or psychiatric applications in humans
More references

Related material